期刊
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING
卷 18, 期 9, 页码 945-960出版社
OXFORD UNIV PRESS
DOI: 10.1093/ehjci/jex094
关键词
arterial hypertension; target organ damage; non-invasive cardiovascular imaging; cardiovascular risk; prognosis
资金
- Medical Research Council [MC_PC_13090] Funding Source: researchfish
- National Institute for Health Research [NF-SI-0509-10222, NF-SI-0514-10011] Funding Source: researchfish
- MRC [MC_PC_13090] Funding Source: UKRI
Arterial hypertension (HTN) accounts for the largest amount of attributable cardiovascular (CV) mortality worldwide, and risk stratification in hypertensive patients is of crucial importance to manage treatment and prevent adverse events. Asymptomatic involvement of different organs in patients affected by HTN represents an independent determinant of CV risk and the identification of target organ damage (TOD) is recommended to further reclassify patients' risk. Non-invasive CV imaging is progressively being used and continues to provide new technological opportunities to TOD evaluation at early stage. The aim of this article is to provide the community of cardiology with an update on appropriate and justified use of non-invasive imaging tests in the growing population of hypertensive patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据